MD1394G2 - Compoziţie implantabilă pentru administrare parenterală care conţine proteină, peptidă sau polipeptidă biologic active şi procedeu de preparare a ei - Google Patents
Compoziţie implantabilă pentru administrare parenterală care conţine proteină, peptidă sau polipeptidă biologic active şi procedeu de preparare a ei Download PDFInfo
- Publication number
- MD1394G2 MD1394G2 MD94-0370A MD940370A MD1394G2 MD 1394 G2 MD1394 G2 MD 1394G2 MD 940370 A MD940370 A MD 940370A MD 1394 G2 MD1394 G2 MD 1394G2
- Authority
- MD
- Moldova
- Prior art keywords
- polypeptide
- peptide
- active protein
- preparation
- biologic active
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 6
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 6
- 229920001184 polypeptide Polymers 0.000 title abstract 3
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 3
- 102000004169 proteins and genes Human genes 0.000 title abstract 3
- 108090000623 proteins and genes Proteins 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 2
- 238000002360 preparation method Methods 0.000 title abstract 2
- 238000007911 parenteral administration Methods 0.000 title 1
- 230000015572 biosynthetic process Effects 0.000 abstract 2
- 239000011248 coating agent Substances 0.000 abstract 2
- 238000000576 coating method Methods 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 239000000843 powder Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/07—Stiffening bandages
- A61L15/10—Stiffening bandages containing organic materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/27—Growth hormone [GH], i.e. somatotropin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Endocrinology (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Neurosurgery (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Materials Engineering (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Materials For Medical Uses (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Prostheses (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US71989891A | 1991-06-24 | 1991-06-24 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| MD940370A MD940370A (en) | 1996-06-28 |
| MD1394F2 MD1394F2 (en) | 2000-01-31 |
| MD1394G2 true MD1394G2 (ro) | 2000-11-30 |
Family
ID=24891827
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MD94-0370A MD1394G2 (ro) | 1991-06-24 | 1994-07-12 | Compoziţie implantabilă pentru administrare parenterală care conţine proteină, peptidă sau polipeptidă biologic active şi procedeu de preparare a ei |
Country Status (24)
| Country | Link |
|---|---|
| EP (1) | EP0523330B1 (enEXAMPLES) |
| JP (1) | JP3597205B2 (enEXAMPLES) |
| KR (1) | KR100221031B1 (enEXAMPLES) |
| CN (1) | CN1050301C (enEXAMPLES) |
| AT (1) | ATE135565T1 (enEXAMPLES) |
| AU (1) | AU656200B2 (enEXAMPLES) |
| BR (1) | BR9202374A (enEXAMPLES) |
| CA (1) | CA2071757C (enEXAMPLES) |
| DE (1) | DE69209173T2 (enEXAMPLES) |
| DK (1) | DK0523330T3 (enEXAMPLES) |
| ES (1) | ES2087337T3 (enEXAMPLES) |
| GE (1) | GEP19970992B (enEXAMPLES) |
| GR (1) | GR3019457T3 (enEXAMPLES) |
| HU (1) | HU217547B (enEXAMPLES) |
| IE (1) | IE74398B1 (enEXAMPLES) |
| IL (1) | IL102287A (enEXAMPLES) |
| LV (1) | LV11816B (enEXAMPLES) |
| MD (1) | MD1394G2 (enEXAMPLES) |
| MX (1) | MX9203175A (enEXAMPLES) |
| RU (1) | RU2080119C1 (enEXAMPLES) |
| SG (1) | SG47955A1 (enEXAMPLES) |
| TW (1) | TW215058B (enEXAMPLES) |
| UA (1) | UA26137C2 (enEXAMPLES) |
| ZA (1) | ZA924613B (enEXAMPLES) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5736152A (en) * | 1995-10-27 | 1998-04-07 | Atrix Laboratories, Inc. | Non-polymeric sustained release delivery system |
| US8052982B2 (en) | 1998-07-20 | 2011-11-08 | Peptech Animal Health Pty Limited | Bioimplant formulation comprising lecithin and stearin |
| ES2389627T3 (es) * | 1998-07-20 | 2012-10-29 | Virbac (Australia) Pty Ltd | Formulación para bioimplantes |
| JP2001058955A (ja) * | 1999-06-17 | 2001-03-06 | Inst Of Physical & Chemical Res | 生理活性ペプチド徐放性製剤 |
| KR100890679B1 (ko) | 2000-02-24 | 2009-03-26 | 일라이 릴리 앤드 캄파니 | 소마토트로핀의 지속적인 방출을 위한 비수성 주사제제들 |
| US6719992B2 (en) | 2000-06-26 | 2004-04-13 | Monsanto Technology Llc | Non-aqueous surfactant-containing formulations for extended release of somatotropin |
| US6664234B1 (en) | 2000-06-30 | 2003-12-16 | Monsanto Technology Llc | Non-aqueous injectable formulation preparation with pH adjusted for extended release of somatotropin |
| JP4931282B2 (ja) * | 2000-10-02 | 2012-05-16 | 日本ケミカルリサーチ株式会社 | 生理活性ペプチド含有粉末 |
| DE10161078A1 (de) * | 2001-12-12 | 2003-08-28 | Achim Goepferich | Matrizes zur Stabilisierung und kontrollierten Freisetzung von Problemarzneistoffen |
| SE526959C2 (sv) * | 2003-10-02 | 2005-11-29 | Tikomed Ab | Bioartificellt implantat innefattande en semipermeabel barriär samt förfarande för reducering av risken för bildning av bindrväv vid implantatet efter implantering genom att barriären förses med en permeabel beläggning av bioaktiv metall |
| JP2005145821A (ja) * | 2003-11-11 | 2005-06-09 | Kao Corp | 打錠製剤 |
| JP2013515080A (ja) | 2009-12-21 | 2013-05-02 | アンブルックス，インコーポレイテッド | 修飾されているウシのソマトトロピンポリペプチドおよびそれらの使用 |
| PE20121799A1 (es) | 2009-12-21 | 2013-01-02 | Ambrx Inc | Polipeptidos de somatotropina porcina modificados y sus usos |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4271113A (en) * | 1978-04-17 | 1981-06-02 | Alza Corporation | Process for forming a passageway in an osmotic device |
| US4795644A (en) * | 1987-08-03 | 1989-01-03 | Merck & Co., Inc. | Device for pH independent release of drugs through the Donnan-like influence of charged insoluble resins |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1257199A (en) * | 1986-05-20 | 1989-07-11 | Paul Y. Wang | Preparation containing bioactive macromolecular substance for multi-months release in vivo |
| US4863736A (en) * | 1987-03-16 | 1989-09-05 | Monsanto Company | Somatotropin prolonged release |
| HUT69680A (en) * | 1990-08-09 | 1995-09-28 | Endocon Inc | Implant and apparatus for delivering multiple drug and process for production of theese |
-
1992
- 1992-04-29 EP EP92107278A patent/EP0523330B1/en not_active Expired - Lifetime
- 1992-04-29 DK DK92107278.1T patent/DK0523330T3/da active
- 1992-04-29 AT AT92107278T patent/ATE135565T1/de not_active IP Right Cessation
- 1992-04-29 SG SG1996005631A patent/SG47955A1/en unknown
- 1992-04-29 ES ES92107278T patent/ES2087337T3/es not_active Expired - Lifetime
- 1992-04-29 DE DE69209173T patent/DE69209173T2/de not_active Expired - Fee Related
- 1992-05-04 TW TW081103470A patent/TW215058B/zh active
- 1992-06-19 JP JP18465792A patent/JP3597205B2/ja not_active Expired - Fee Related
- 1992-06-22 IL IL10228792A patent/IL102287A/xx not_active IP Right Cessation
- 1992-06-22 CA CA002071757A patent/CA2071757C/en not_active Expired - Fee Related
- 1992-06-23 HU HU9202092A patent/HU217547B/hu not_active IP Right Cessation
- 1992-06-23 RU SU925052163A patent/RU2080119C1/ru not_active IP Right Cessation
- 1992-06-23 AU AU18470/92A patent/AU656200B2/en not_active Ceased
- 1992-06-23 KR KR1019920010911A patent/KR100221031B1/ko not_active Expired - Fee Related
- 1992-06-23 CN CN92105065A patent/CN1050301C/zh not_active Expired - Fee Related
- 1992-06-23 ZA ZA924613A patent/ZA924613B/xx unknown
- 1992-06-23 MX MX9203175A patent/MX9203175A/es not_active IP Right Cessation
- 1992-06-23 BR BR929202374A patent/BR9202374A/pt not_active Application Discontinuation
- 1992-07-01 IE IE922020A patent/IE74398B1/en not_active IP Right Cessation
-
1993
- 1993-06-15 UA UA93002879A patent/UA26137C2/uk unknown
- 1993-07-31 GE GEAP19931351A patent/GEP19970992B/en unknown
-
1994
- 1994-07-12 MD MD94-0370A patent/MD1394G2/ro unknown
-
1996
- 1996-03-29 GR GR950403216T patent/GR3019457T3/el unknown
-
1997
- 1997-03-05 LV LVP-97-37A patent/LV11816B/xx unknown
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4271113A (en) * | 1978-04-17 | 1981-06-02 | Alza Corporation | Process for forming a passageway in an osmotic device |
| US4795644A (en) * | 1987-08-03 | 1989-01-03 | Merck & Co., Inc. | Device for pH independent release of drugs through the Donnan-like influence of charged insoluble resins |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MD1394G2 (ro) | Compoziţie implantabilă pentru administrare parenterală care conţine proteină, peptidă sau polipeptidă biologic active şi procedeu de preparare a ei | |
| CA2039491A1 (en) | Stable compositions for parenteral administration and method of making same | |
| CA2095153A1 (en) | Genetic modification of endothelial cells | |
| CA2068324A1 (en) | Metal-peptide compositions and methods for stimulating hair growth | |
| CA2214788A1 (en) | Controlled dissolution pellet containing calcium sulfate | |
| DE3369070D1 (en) | Lyophilized compositions, preparation and use thereof | |
| EP0072469A3 (en) | Method for making a pharmaceutical and/or nutritional dosage form | |
| KR850007559A (ko) | 조절 펩타이드의 삽입식 제형 | |
| HUP9802287A2 (hu) | Cinkkel és kívánt esetben lizinnel vagy kalciumionnal előkezelt növekedési hormont tartalmazó stabilizált gyógyszerkészítmény | |
| CA2009890A1 (en) | Valproic acid | |
| IL76440A0 (en) | Growth hormone releasing factor analogs,their preparation and pharmaceutical compositions containing them | |
| ES2016731A6 (es) | Procedimiento para la obtencion de un aglutianante hidraulico modificado. | |
| JPS6445318A (en) | Delivery system for administration control of lhrh analogue | |
| IL90864A0 (en) | Substituted 1,7-annelated 1h-indazoles,their preparation and pharmaceutical compositions containing them | |
| IL52936A0 (en) | A coating ensuring a controlled release of active ingredients of biologically active compositions particularly pharmaceutical compositions its production and preparations having such a coating | |
| HUT41365A (en) | Insecticide compositions containing substituted benzyl-ether derivatives as active ingredients and process for preparing the active substances | |
| AU8215791A (en) | Method for preparing a lipoprotein modified by the incorporation of a lipophilic active substance | |
| ES8303085A1 (es) | Un procedimiento para la preparacion de una composicion antitranspirante a base de sales de aluminio y zirconio. | |
| YU45988B (sh) | Postupak za izradu čvrste kompozicije za oralnu upotrebu na bazi nifedipina sa kontrolisanim otpuštanjem aktivne supstance | |
| DE69306243D1 (de) | Zusammensetzungen mit verzögerter wirkstoffabgabe | |
| PL334526A1 (en) | Novel inhalable preparation of 0.28 to 0.38 g/ml bulk density containing terbutaline sulphate, method of obtaining such preparation and application thereof | |
| AU4150489A (en) | Micronised drug formulation | |
| AU587626B2 (en) | Continuous release peptide composition | |
| RU97114578A (ru) | Биологически активная добавка к пище "коррида" для отвыкания от курения | |
| PT80401A (en) | Process for the preparation of biologically active compositions containing substituted isoxazolidines new substituted isoxazolidines and intermediate products used in their preparation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PD99 | Pending application |